DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
48 hedge funds and large institutions have $71.1M invested in Dicerna Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-5
Holders Change %
-9.43%
% of All Funds
1.28%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
7
Increased
8
Reduced
17
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ARTA
51
A.R.T. Advisors
New York
| – | -$170K | -56,763 | Closed |
|
|
TC
52
TFS Capital
West Chester,
Pennsylvania
| – | -$91K | -30,429 | Closed |
|
53
Two Sigma Investments
New York
| – | -$90K | -30,134 | Closed |
|
|
AGM
54
Alpine Global Management
New York
| – | -$61K | -20,488 | Closed |
|
55
Squarepoint
New York
| – | -$49K | -16,300 | Closed |
|
|
LP
56
LMR Partners
London,
United Kingdom
| – | -$35K | -11,757 | Closed |
|
57
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$33K | -11,130 | Closed |
|
58
Jane Street
New York
| – | -$31K | -10,274 | Closed |
|
59
Barclays
London,
United Kingdom
| – | -$6K | -1,842 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$4K | -1,220 | Closed |
|